Cosmos Health Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a COSM research report →
Price Chart
About the company
Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace.
- CEO
- Grigorios Siokas
- IPO
- 2010
- Employees
- 163
- HQ
- Thessaloniki, IL, GR
Get TickerSpark's AI analysis on COSM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $14.14M
- P/E
- -0.21
- Fwd P/E
- 3.29
- PEG
- -0.00
- P/S
- 0.19
- P/B
- 0.41
- EV/EBITDA
- -1.45
- Div Yield
- 0.00%
- Gross Margin
- 10.27%
- Op Margin
- -24.65%
- Net Margin
- -33.08%
- ROE
- -118.89%
- ROIC
- -46.45%
Latest fiscal year · YoY change
- Revenue
- $65.27M+19.9%
- Gross Profit
- $7.90M+83.1%
- Op Income
- $-16,540,819
- Net Income
- $-19,144,998-18.3%
- EPS
- $-12.60+46.2%
- OCF Growth
- -9.5%
- FCF Growth
- -4.5%
- 52W High
- $14.36
- 52W Low
- $2.20
- 50D MA
- $5.94
- 200D MA
- $5.85
- Beta
- 4.44
- RSI (14)
- 33
- Avg Volume
- 163.08K
No earnings-call transcripts are available for COSM yet.
- Free Float
- 74.5%
- Shares Outstanding
- 5.03M
- Float Shares
- 3.75M
of shares held by institutions
21 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Wells Fargo & Company/Mn | 5.12M | ▲ 5.12M |
| Geode Capital Management, LLC | 405.39K | ▲ 123.30K |
| Ubs Group AG | 352.80K | ▼ 241.66K |
| Vanguard Capital Management LLC | 304.12K | ▲ 130.15K |
| Blackrock, Inc. | 267.80K | 0 |
| Vanguard Group Inc | 235.74K | 0 |
| Vanguard Fiduciary Trust Co | 148.18K | ▼ 185.67K |
| Susquehanna International Group, Llp | 138.28K | ▲ 138.28K |
| Citigroup Inc | 113.14K | ▲ 113.09K |
| Xtx Topco Ltd | 80.33K | ▲ 80.33K |
| Raymond James Financial Inc | 67.39K | ▲ 67.39K |
| Citadel Advisors LLC | 57.50K | ▲ 57.50K |
Held by 6 ETFs
Biggest fund positions in COSM by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 30, 26 | Siokas Grigorios | buy | 349,825 |
| Jul 29, 26 | Terzis Georgios | other | 328,407 |
| Jul 29, 26 | Siokas Grigorios | buy | 766,284 |
| Jun 16, 26 | Terzis Georgios | buy | 168,135 |
| Jun 11, 26 | Siokas Grigorios | buy | 218,447 |
| Jun 10, 26 | Siokas Grigorios | buy | 701,447 |
| May 19, 26 | Karkantzos Theodoros Christos | other | 20,000 |
| May 19, 26 | Karkantzos Theodoros Christos | other | 35,000 |
| May 19, 26 | Hoidas John James | other | 20,000 |
| May 19, 26 | Hoidas John James | other | 20,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our COSM coverage
Recent articles, reports, and earnings notes.
No research on COSM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate COSM report →Cosmos Health Expands E-Commerce and Subscription Business to Australia, New Zealand and the Broader Oceania Region, With Sales Already Underway
accessnewswire.com · Oct 22
Cosmos Health CEO Greg Siokas Issues Letter to Shareholders Highlighting Record 2026 Revenue, U.S. Subscription Growth and Global Expansion
accessnewswire.com · Oct 20
Cosmos Health Provides Update on United States Business; Q4 2026 U.S. Revenue Expected to Reach $15 Million, with Gross Profit of $10.5 Million; Active U.S. Subscriptions Up 42% from 6,287 to 8,940 in Just Five Days
accessnewswire.com · Oct 19
Cosmos Health Reaches 6,287 Active U.S. Subscriptions, Substantially All Added Since Mid-September, with 60.5% of Online Checkout Orders Including a Subscription
accessnewswire.com · Oct 14
Cosmos Health Reports Record Single-Day Direct-to-Consumer Sales in the United States Above $92,000, with $902,000 in Sales Over the Past 30 Days
accessnewswire.com · Oct 13
Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million
accessnewswire.com · Oct 7
Cosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 Billion
accessnewswire.com · Oct 1
Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue
accessnewswire.com · Sep 29
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.